Study of immune cells in autoimmune anemia before and after treatment
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study looks at specific immune cells in people with autoimmune hemolytic anemia, before starting treatment and after treatment. It may help researchers understand what role these immune cells play and how treatment affects the immune system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with autoimmune hemolytic anemia (primary or secondary).
- You are not currently taking treatment for the condition when you join the study.
- You can join if you are male or female of any age.
- You are not pregnant and not breastfeeding.
- You are not taking steroid medicines (corticosteroids) or other immune-suppressing medicines.
- You do not have a blood cancer (hematological malignancy) and your anemia is not from ABO blood-group incompatibility or a transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with autoimmune blood problems like autoimmune hemolytic anemia, immune thrombocytopenia, and autoimmune/neutropenia to see how diagnosis and care work over time. You may be asked to complete follow-up visits for up to 3 years.
This trial tests a new cell therapy called YTS109 for people with autoimmune hemolytic anemia (AIHA) that hasn't improved with standard treatments. The goal is to see if this therapy can help control the disease when other options have failed.
This trial tests an experimental cell therapy called YTS109 for people with autoimmune hemolytic anemia (AIHA) that hasn't improved after at least three prior treatments. It aims to see if the therapy can help control the disease and improve anemia symptoms.
This study is looking for people about to start immune checkpoint inhibitor therapy to see if certain antibodies are present. It may help understand how the body reacts to this treatment.
This study looks at immune cells in people with certain autoimmune diseases or immune deficiencies. The goal is to understand how these cells work, which may help improve future treatments.
This study looks at blood cell changes that can affect the immune system. It aims to better understand how these changes relate to immune problems and related diseases, and what might matter for treatment decisions.
Hear when a new Autoimmune Hemolytic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.